Differential regulation of insulin action and tumor necrosis factor α system activity by metformin

Metabolism: Clinical and Experimental

Volumn 54, Issue 2, 2005, Pages 235-239

  Biarnés, Josefina ^a   Fernández Real, José Manuel ^a   Fernández Castañer, Miguel ^b   García, Maria Del Mar ^a   Soler, Juan ^b   Ricart, Wilfredo ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; METFORMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE TOLERANCE; HEARTBURN; HOMEOSTASIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NAUSEA; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; METFORMIN; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12944322215     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.08.018     Document Type: Article

References (41)

1. S.M. Haffner, M.P. Stern, and H.P. Hazuda Cardiovascular risk factors in confirmed prediabetic individuals JAMA 263 1990 2893 2898
2. E. Bonora, S. Kiechl, and F. Oberhollenzer Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study Diabetologia 43 2000 156 164
3. N. Unwin, J. Shaw, and P. Zimmet International diabetes federation IGT/IFG consensus statement Diabet. Med. 19 2002 708 723
4. S. Lillioja Impaired glucose tolerance in Pima Indians Diabet. Med. 13 1996 S127 S132
5. G.K. Dowse, P.Z. Zimmet, and V.R. Collins Insulin levels and the natural history of glucose intolerance in Nauruans Diabetes 45 1996 1367 1372
6. J.H. Warram, R.J. Sigal, and B.C. Martin Natural history of impaired glucose tolerance: follow-up at Joslin Clinic Diabet. Med. 13 1996 S40 S45
7. W. Pimenta, A. Mitrakou, and T. Jensen Insulin secretion and insulin sensitivity in people with impaired glucose tolerance Diabet. Med. 13 1996 S33 S36
8. K.S. Polonsky, J. Sturis, and G.I. Bell Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance N. Engl. J. Med. 12 1996 777 783
9. H. Larsson, and B. Ahren Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women Diabetologia 43 2000 194 202
10. X.R. Pan, G.W. Li, and Y.H. Hu Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance Diabetes Care 20 4 1997 537 544
11. J. Tuomilehto, J. Lindström, and J.G. Eriksson Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 344 2001 1343 1350
12. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 6 2002 393 403
13. T.A. Buchanan, A.H. Xiang, and R.K. Peters Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women Diabetes 51 2002 2796 2803
14. J.L. Chiasson, R.G. Josse, R. Gomis for the STOP-NIDDM Trial Research Group Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet 359 2002 2072 2077
15. D. Kirpichnikov, S.I. McFarlane, and J.R. Sowers Metformin: an update Ann. Intern. Med. 137 2002 25 33
16. G. Zhou, R. Myers, and Y. Li Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
17. D. Aderka, H. Engelmann, and Y. Maor Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J. Exp. Med. 175 1992 323 329
18. Y. Nophar, O. Kemper, and C. Brakebusch Soluble forms of tumor necrosis factors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor EMBO J. 9 1990 3269 3278
19. D. Aderka, P. Sorkine, and S. Abu-Abid Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock J. Clin. Invest. 101 3 1998 650 659
20. J. Schroder, F. Stuber, and H. Gallati Pattern of soluble TNF receptors I and II in sepsis Infection 23 1995 143 148
21. D. Aderka, H. Engelmann, and Y. Shemer-Avni Variation in serum levels of the soluble TNF receptors among healthy individuals Lymphokine Cytokine Res. 11 1992 157 159
22. J.M. Fernández-Real, M. Broch, and W. Ricart Plasma levels of the soluble fraction of tumor necrosis factor receptor-2 and insulin resistance Diabetes 47 1998 1757 1762
23. S.S. Solomon, S.K. Mishra, and C. Cwik Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells Horm. Metab. Res. 29 8 1997 379 382
24. H.Z. Lin, S.Q. Yang, and C. Chuckaree Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat. Med. 6 9 2001 998 1003
25. M. Straczkowski, I. Kowalska, and A. Stepien Increased plasma-soluble tumor necrosis factor-α receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects Diabetes Care 25 2002 1824 1828
26. S. Tsukui, T. Kanda, and M. Nara Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women Int. J. Obes. Relat. Metab. Disord. 24 2000 1207 1211
27. J.M. Fernández-Real, B. Laínez, and J. Vendrell Shedding of tumor necrosis factor-alpha receptors, blood pressure and insulin sensitivity in type 2 diabetes mellitus Am. J. Physiol. Endocrinol. Metab. 282 2002 E952 E959
28. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 28 1979 1039 1057
29. D.R. Mathews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
30. E. Bonora, G. Targher, and M. Alberiche Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity Diabetes Care 23 2000 57 63
31. J.P. Hosker, D.R. Matthews, and A.S. Rudenski Continuous infusion of glucose with model assessment: measurement of insulin resistance and B-cell function in man Diabetologia 28 1985 401 411
32. G. Mithieux, G. Ludovic, and J.-C. Bordet Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet Diabetes 51 2002 139 143
33. N. Musi, M.F. Hirshman, and J. Nygren Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes Diabetes 51 2002 2074 2081
34. M. Straczkowski, I. Kowalska, and S. Dzienis-Straczkowska Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance Eur. J. Endocrinol. 145 2001 273 280
35. A. Costa, J.M. Fernandez-Real, and J. Vendrell Lower rate of tumor necrosis factor-alpha-863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes Metabolism 52 8 2003 1068 1071
36. Y. Morel, A. Golay, and T. Perneger Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance Diabet. Med. 16 1999 650 655
37. C.L. Li, C.Y. Pan, and J.M. Lu Effect of metformin on patients with impaired glucose tolerance Diabet. Med. 16 1999 477 481
38. S.M. Carlsen, A. Waage, and V. Grill Metformin increases circulating tumor necrosis factor-α levels in non-obese non-diabetic patients with coronary heart disease Cytokine 10 1998 66 69
39. J.M. Fernández-Real, and W. Ricart Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness Diabetologia 42 1999 1367 1374
40. J.M. Fernández-Real, and W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome Endocr. Rev. 24 2003 278 301
41. A.T. Cheung, D. Ree, and J.K. Kolls An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-α Endocrinology 139 1998 4928 4935